维普中文期刊产品整合服务
13篇 您的检索式:作者名="Kruit WH"
    题名 作者 年代 出处 被引量
1Phase I/II study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma 显示文摘Kruit WH van Ojik HH Brichard VG 2005Int J Cancer2005,117,4:1
2Phase 1 study of subcutaneously administered recombinant human interleukin-12 in patients with advanced renal cell cancer 显示文摘Portielje JE Kruit WH Schuler M 1999Clin Cancer Res1999,5,12:1
3Repeated administrations of interleukin (IL) -12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL- 6, and IL-8 responses显示文摘Portielje JE Lamers CH Kruit WH 2003Clin Cancer Res2003,9,1:1
4Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma显示文摘Kruit WH Van Ojik HH Brichard VG 2005Int J Cancer2005,117,4:1
5Selection of immunos-timulant AS15 for active immunization with MAGE-A3 pro-tein :results of a randomized phase II study of the Euro-pean Organisation for Research and Treatment of CancerMelanoma Group in Metastatic Melanoma 显示文摘Kruit WH Suciu S Dreno B 2013J Clin Oncol2013,31,19:1
6Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma显示文摘Kruit WH van Ojik HH Brichard VG 2005Int J Cancer2005,117,6:1
7Docetaxel (Tax- otere): an active agent in metastatic urothelial cancer; re- sults of a phase II study in non-chemotherapy-pretreated patients显示文摘De Wit R Kruit WH Stoter G 1998Br J Cancer1998,78,:1
8Interferon-αin oncology patients:Fewer psychiatric side effects than anticipated显示文摘Bannink M Kruit WH Gool AR 2008Psycho-somatics2008,49,1:1
9Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma,tumor necrosis factor-alpha,IL-6,and IL-8 responses显示文摘Portielje JE Lamers CH Kruit WH 2003Clin Cancer Res2003,9,1:1
10Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma 显示文摘Kruit WH van Ojik HH Brichard VG 2005Int J Cancer2005,117,4:1
11Docetaxel (Taxotere) :an active agent in metastatic urothelial cancer : results of a phase II study in non-chemotherapy-pretreated patients显示文摘DE WIT R KRUIT WH STOTER G 1998Br J Cancer1998,78,10:1
12Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer显示文摘Portielje JE Kruit WH Schuler M 1999Clin Cancer Res1999,5,12:1
13Docetaxel (Taxo- tere): an active agent in metastatic urothelial cancer; results of a phase I] study in non-chemotherapy-pretreated patients 显示文摘de Wit R Kruit WH Stoter G 1998Br J Cancer1998,78,10:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费